Skip to main content

Table 3 Prolactin and total cholesterol levels (mean ± SD) according to treatment group and evaluation moment

From: Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study

Measurement

Serum Levels in Treatment Group

p-value*

 

A (1 g)

B (2 g)

C (Placebo)

 

Prolactin

    

   Baseline

7.54 ± 2.1

7.87 ± 2.5

8.24 ± 3.4

 

   6 months

7.03 ± 1.7

7.75 ± 2.7

7.58 ± 3.5

0.3282

Total cholesterol

    

   Baseline

178.8 ± 13.9

172.6 ± 28.1

180.2 ± 14.1

 

   6 months

176.2 ± 14.3

177.1 ± 10.2

179.2 ± 14.8

0.3364

  1. * Comparison of the relative variation (%) between groups (ANOVA).